ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE

ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g ., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IÑIGO TIRAPU FERNANDEZ DE LA CUESTA, MATTHEW COLIN THOR FYFE, MARC MARTINELL PEDEMONTE, MARIA DE LOS ÁNGELES ESTIARTE-MARTÍNEZ, ALBERTO ORTEGA MUÑOZ
Format: Patent
Sprache:eng ; por
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g ., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.